Comprehensive Bioinformatics Evaluation within the Left Atrial Appendage from Individuals with Atrial Fibrillation to Enhance the Comprehension of Atrial Fibrillation-Related Thrombus Development

DOI: https://doi.org/10.62517/jmhs.202605307

Author(s)

Changqing Li, Duo Wang, Tingting Lv, Peng Liu*

Affiliation(s)

Department of Cardiology, Ordos Cental Hospital, Ordos, Inner Mongolia, China *Corresponding Author

Abstract

To investigate differentially expressed genes and their potential functions in left atrial appendage tissues from patients with atrial fibrillation through integrated bioinformatics analysis, providing a theoretical basis for the molecular mechanisms underlying AF-related thrombus formation. Two gene expression datasets, GSE79768 and GSE115574, were obtained from the GEO database. A total of 14 left atrial appendage samples from AF patients and 16 from sinus rhythm controls were included. Differentially expressed genes were screened using the limma package. Gene Ontology functional annotation and KEGG pathway enrichment analyses were performed using DAVID and KOBAS databases, and a protein-protein interaction network was constructed using the STRING database. A total of 96 common differentially expressed genes were identified, including 69 upregulated and 27 downregulated genes. GO analysis indicated that these genes were predominantly enriched in biological processes such as cell surface, antigen processing and presentation, and immune response. KEGG analysis suggested significant enrichment of differentially expressed genes in the phagosome pathway, as well as signaling pathways related to Staphylococcus aureus infection and tuberculosis. PPI network analysis identified 20 hub genes, including TYROBP, CD53, and CTSS. Differentially expressed genes in left atrial appendage tissues of AF patients are primarily involved in immune-inflammatory responses and phagosome-related pathways. These molecules may participate in the regulatory processes of thrombus formation under AF conditions.

Keywords

Atrial Fibrillation; Left Atrial Appendage; Thrombosis; Differentially Expressed Genes; Bioinformatics

References

[1] Magnussen C, Niiranen TJ, Ojeda FM, et al. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts. Circulation. 2018:1. [2] Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61(2):755-759. [3] Lim HS, Willoughby SR, Schultz C, et al. Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm. J Am Coll Cardiol. 2013; 61(8):852-860. [4] Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009; 373(9658):155-166. [5] Zou R, Yang M, Shi W, et al. Analysis of Genes Involved in Persistent Atrial Fibrillation: Comparisons of ‘Trigger’ and ‘Substrate’ Differences. Cell Physiol Biochem. 2018; 47(3):1299-1309. [6] Yeh Y, Kuo C, Lee Y, et al. Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation. Heart Rhythm. 2013; 10(3):383-391. [7] Dobrev D, Wehrens XHT. Calcium-mediated cellular triggered activity in atrial fibrillation. The Journal of Physiology. 2017; 595(12):4001-4008. [8] Voigt N, Heijman J, Wang Q, et al. Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation. Circulation. 2014; 129(2):145-156. [9] Tsai F, Lin Y, Chang S, et al. Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis. Int J Cardiol. 2016; 222:104-112. [10]Adam O, Lavall D, Theobald K, et al. Rac1-Induced Connective Tissue Growth Factor Regulates Connexin 43 and N-Cadherin Expression in Atrial Fibrillation. J Am Coll Cardiol. 2010; 55(5):469-480. [11]Peng S, Li K, Man Y, et al. Identification of ferroptosis biomarkers and immune infiltration landscapes in atrial fibrillation: A bioinformatics analysis. Medicine, 2024, 103(39): e39777. [12]Xue Z, Zhu J, Liu J, et al. Circular RNAs in atrial fibrillation: From bioinformatics analysis of circRNA-miRNA-mRNA network to serum expression. Biochemistry and Biophysics Reports, 2023, 36: 101577. [13]Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. [14]Sherman BT, Huang DW, Tan Q, et al. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. Bmc Bioinformatics. 2007; 8: 426. [15]Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017; 45(D1):D362-D368. [16]Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation. J Am Heart Assoc. 2015; 4(1). [17]Kishore A VAMA. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: asystematic review and meta-analysis. Stroke. 2014; 45:520-526. [18]Xiong Q PMSK. Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. Int J Cardiol. 2015; 191:172-177. [19]Guo Y, Lip GYH, Apostolakis S. Inflammation in Atrial Fibrillation. J Am Coll Cardiol. 2012; 60(22):2263-2270. [20]Zacharia E, Papageorgiou N, Ioannou A, et al. Inflammatory biomarkers in atrial fibrillation. Current medicinal chemistry, 2019, 26(5): 837-854. [21]Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol. 2010; 21(9):1064-1070. [22]Marzilli M, Merz C N B, Boden W E, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! . Journal of the American College of Cardiology, 2012, 60(11): 951-956. [23]Harrison D G, Guzik T J, Lob H E, et al. Inflammation, immunity, and hypertension. Hypertension, 2011, 57(2): 132-140. [24]Hu Y F, Chen Y J, Lin Y J, et al. Inflammation and the pathogenesis of atrial fibrillation . Nature Reviews Cardiology, 2015, 12(4): 230-243. [25]Marcus G M, Smith L M, Ordovas K, et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation . Heart rhythm, 2010, 7(2): 149-154. [26]Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart rhythm, 2010, 7(4): 438-444. [27]Hu Y F, Yeh H I, Tsao H M, et al. Electrophysiological correlation and prognostic impact of heat shock protein 27 in atrial fibrillation. Circulation: Arrhythmia and Electrophysiology, 2012, 5(2): 334-340. [28]Duygu H, Barisik V, Kurt H, et al. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation. Europace, 2008, 10(2): 210-214. [29]GY L I P. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke, 2007, 38(4): 1229-1237. [30]Jv R. IgG Fc receptors. Annu Rev Immunol., 2001, 19: 275-290. [31]Bournazos S. IgG Fc receptors: evolutionary considerations. Fc Mediated Activity of Antibodies: Structural and Functional Diversity, 2019: 1-11. [32]Stuart LM, Ezekowitz RAB. Phagocytosis. Immunity. 2005; 22(5):539-550. [33]Haemers P, Hamdi H, Guedj K, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017; 38(1):53-61. [34]Beers C, Burich A, Kleijmeer M J, et al. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo . The Journal of Immunology, 2005, 174(3): 1205-1212. [35]LL L. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature, 1998, 391: 703-707. [36]Tomasello E, Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol. 2005; 35(6):1670-1677. [37]Shao Q, Chen K, Rha S W, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis . Archives of medical research, 2015, 46(3): 199-206. [38]Gibson P H, Cuthbertson B H, Croal B L, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. The American journal of cardiology, 2010, 105(2): 186-191. [39]Ak K, Akgun S, Tecimer T, et al. Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery . The Annals of thoracic surgery, 2005, 79(6): 1970-1975. [40]Maesen B, Nijs J, Maessen J, et al. Post-operative atrial fibrillation: a maze of mechanisms. Europace, 2012, 14(2): 159-174. [41]Wang C, Yu S, Bao Q, et al. Circulating Mesencephalic Astrocyte-Derived Neurotrophic Factor Negatively Correlates With Atrial Apoptosis in Human Chronic Atrial Fibrillation. J Cardiovasc Pharm. 2020; 75(2):141-147. [42]Aime-Sempe C, Folliguet T, Rucker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol. 1999;34(5):1577-1586 [43]Joglar J A, Chung M K, Armbruster A L, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines . Journal of the American College of Cardiology, 2024, 83(1): 109-279. [44]Yang J, Tan H, Sun M, et al. Single‐cell RNA sequencing reveals a mechanism underlying the susceptibility of the left atrial appendage to intracardiac thrombogenesis during atrial fibrillation . Clinical and Translational Medicine, 2023, 13(6): e1297. [45]Li N, Wang L, Li L, et al. The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives. Military Medical Research, 2023, 10(1): 51.